12
Participants
Start Date
March 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
July 31, 2014
Levothyroxine therapy (137.75 ± 23.75 μg/day)
This study was a longitudinal study in an academic center, with a follow-up period of 6 months. Ten patients with well-differentiated thyroid carcinoma eligible for surgical treatment and subsequent radioactive iodine ablation therapy were studied in a hypothyroid state after thyroidectomy and in a subclinical hyperthyroid state (TSH-suppression according to standard treatment protocol).
Maastricht UMC, Maastricht
Maastricht University Medical Center
OTHER